Scoop has an Ethical Paywall
Douglas Pharmaceuticals to remain in family ownership
MEDIA RELEASE - November 30, 2012
Douglas Pharmaceuticals to remain in family ownership
Auckland, New Zealand November 30, 2012: New Zealand’s largest pharmaceutical manufacturer is to remain in family ownership.
The company had received a number of purchase offers over the years and recently decided to formalise the process through an Information Memorandum (IM) to prospective purchasers via its advisors Deutsche Bank.
After receiving the offers, Douglas Pharmaceuticals’ founder and managing director, Sir Graeme Douglas considers the best way forward for the company is to retain its private ownership. The company will bolster its export activities through the addition of experienced and qualified executives with emphasis on emerging markets in Asia and Latin America.
“Along with my Board, I remain committed and passionate about the future of our New Zealand-manufactured pharmaceuticals enjoying ever-increasing success in the world markets.”
Founded
in 1967 by Sir Graeme Douglas, the company employs 460
people marketing and distributing its product domestically,
and exporting to a further 45 countries worldwide, including
recent launches in the USA.
ends
UN Department of Global Communications: United Nations Proposes New Global Dashboard To Measure Progress Beyond GDP
Banking Ombudsman Scheme: Fraud Check Delays Well Worth The Inconvenience, Says Banking Ombudsman
Asia Pacific AML: NZ’s Financial Crime Gap - Beyond The 'Number 8 Wire' Mentality
Westpac New Zealand: Kiwi Households Adapting Despite Widespread Cost Pressure Concerns, Westpac Survey Shows
University of Auckland: Kids’ Screen Use Linked To Long-Term Deficits In Self-Control And Attention
University of Auckland: Research To Address Equity In STEM For Māori, Pacific And Female Students
